Sawai Group Holdings Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SWGHF research report →
About the company
Sawai Group Holdings Co. , Ltd. , along with its subsidiaries, specializes in the research, development, manufacture, and commercialization of generic pharmaceuticals, primarily serving markets in Japan and the United States.
- CEO
- Mitsuo Sawai
- IPO
- 2021
- Employees
- 3,482
- HQ
- Osaka, JP
Price Chart
- Market Cap
- $1.33B
- P/E
- 18.76
- P/S
- 0.98
- P/B
- 1.11
- EV/EBITDA
- 9.79
- Div Yield
- 3.20%
- Gross Margin
- 29.15%
- Op Margin
- 10.01%
- Net Margin
- 5.18%
- ROE
- 5.88%
- ROIC
- 5.56%
- Revenue
- $202.95B · 7.36%
- Net Income
- $10.50B · -54.21%
- EPS
- $91.07 · -50.78%
- Op Income
- $20.48B
- FCF YoY
- -1886.55%
- 52W High
- $11.52
- 52W Low
- $11.52
- 50D MA
- $11.52
- 200D MA
- $11.52
- Beta
- 0.03
- Avg Volume
- 68.88
Get TickerSpark's AI analysis on SWGHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SWGHF coverage
Recent articles, reports, and earnings notes.
No research on SWGHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SWGHF report →Similar companies
Peers in the same neighborhood.